1/50
Looks like no tags are added yet.
cancer is a condition characterized by
the uncontrolled growth and proliferation of cells
what is the number one cause of death for veterinary patients?
cancer
causes of cancer include
genetics
environment
infectious
dietary
hormonal
chronic inflammation/trauma
heritable cancers in dogs
GSD → RCND
bernese mountain dogs → histiocytic sarcoma
scottish deerhound → osteosarcoma
goldens → hemangiosarcoma
shelties, scotties, westies, beagles, yorkies → TCC
many breeds → lymphoma
environmental factors that can cause cancer
tobacco smoke
pesticides, herbicides, and insecticides → TCC in dogs
living environment → lymphoma
sunlight → HSA and SCC
radiation → SCC and OSA
asbestos → mesothelioma

what is this?
hemangiosarcoma

what is this?
squamous cell carcinoma
tobacco smoke
humans → 30% of deaths in USA
dogs → 3.4 fold increased risk (lymphoma, nasal carcinomas)
cats → 2.4 fold increased risk (lymphoma, oral SCC)
pesticides, herbicides, insecticides
2,4-D dichlorophenoxyacetic acid pesticides → lymphoma in humasn and dogs
2,4-D and 4-chloro-2-methylphenoxy acetic acid → TCC of the bladder in dogs
FeLV
60 fold increased risk for lymphoma
insertional mutagenesis
FIV
4 fold increased risk for lymphoma
FeLV/FIV co-infection
synergistic risk
80 fold increased risk for lymphoma
spirocerca lupi
esophageal fibrosarcoma
schistosomiasis
bladder cancer
FeSV
multifocal sarcomas
papillomavirus
cutaneous warts
marek’s disease
herpes virus and lymphoma
bovine leukemia virus =
lymphoma
hormonal factors
sex hormones in females
mammary cancer in dogs and cats → intact female dogs 7x increased risk
cats → aggressive, often rapidly fatal disease
spaying before 6 months
trauma/chronic inflammation
may lead to malignant transformation
feline ocular sarcoma
feline injection site sarcoma
IBD
appropriate treatment or combination of treatments is determined by
tumor stage, tumor type, other factors like owner finances, capabilities, etc
what are the 3 main therapeutic modalities?
divided into local vs systemic
local therapies → surgery, radiation
systemic therapies → chemotherapy
tumor stage often dictates appropriate treatment like
bulky disease treated by local therapy such as surgery
tumor behavior determines
appropriate treatment → infiltrative growth, metastatic rate
surgery for cancer
best cancer control with exceptions → lymphoproliferative diseases, metastatic diseases
can be diagnostic or therapeutic
what is the main indication for surgery for cancer?
solid (localized) tumors
limitations of surgery for cancer
patient health, cost, morbidity/mortality, systemic or advanced tumors
toxicity from surgery
infection, incomplete resection, dehiscence, tumor seeding
radiation therapy
utilizes ionizing radiation to destroy tumor cells
used to treat small amounts of residual tumor cells
can also be used to reduce pain symptoms
limitations → cost, availability, localized lesions
chemotherapy
involves use of cytotoxic drugs with narrow therapeutic indices to treat primary tumors, prevent/treat metastatic lesions, palliate tumor-related symptoms
targeted drugs are becoming more common
treatment can be used as → sole modality, additive therapy, palliative therapy
induction chemotherapy
using chemo as a sole therapy to treat primary tumors
indications for induction chemotherapy
chemosensitive tumors → LSA, plasmacytomas, TVT
palliation
intralesional
adjuvant
adding chemotherapy to some other regimen such as following surgery or FT for tumors with high metastatic rates
indications for adjuvant chemo
additional local control
intralesional
metastatic tumors
palliation
neoadjuvant
using chemotherapy in hopes of downstaging tumors prior to surgery or other regimens
indications for neoadjuvant therapy
surgery not feasible
investigational drugs
test dose
photodynamic therapy
administration and activation of photoactive agent
cryotherapy
local therapy for select superficial tumors
hyperthermia
local therapy typically combined with surgery or radiation
immunotherapy
systemic therapy for select tumors
definitive therapy
desired goal is long-term control
more expensive, higher morbidity
palliative therapy
desired goal is the reduction of tumor-related symptoms
less expensive, lower morbidity
median survivial time
point of time at which 50% of patients have succumbed d/t cancer
assumes normal distribution
disease-free interval
length of time from disease resolution to recurrence of death from disease
cure
control such that DFI >3 years
complete response to therapy
cure → complete disappearance of cancer, patient has normal life expectancy
complete remission → complete disappearance of cancer for a minimum of 2 dosing intervals
partial response to therapy
partial remission → 30-50% or greater decrease in tumor burden and no new disease for a minimum of 2 dosing intervals
overall response rate =
CR + PR
stable disease
<50% decrease and no more than a 25% increase in tumor burden for a minimum of 2 dosing intervals
progressive disease
25% increase in tumor burden and/or the development of new lesions (in spite of therapy)
palliative responses to therapy
improved quality of life
measured using performance scale in humans
decreased symptom-ology
increased well being
dose not directly equate with improved survival